Feasibility and safety of electrochemotherapy (ECT) in the pancreas: a pre-clinical investigation

BACKGROUND. Pancreatic ductal adenocarcinoma (PDAC) is a lethal disease generally refractory to standard chemotherapeutic agents; therefore improvements in anticancer therapies are mandatory. A major determinant of therapeutic resistance in PDAC is the poor drug delivery to neoplastic cells, mainly...

Descripción completa

Detalles Bibliográficos
Autores principales: Girelli, Roberto, Prejanò, Simona, Cataldo, Ivana, Corbo, Vincenzo, Martini, Lucia, Scarpa, Aldo, Claudio, Bassi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Versita, Warsaw 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4387991/
https://www.ncbi.nlm.nih.gov/pubmed/26029026
http://dx.doi.org/10.1515/raon-2015-0013

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4387991/
https://www.ncbi.nlm.nih.gov/pubmed/26029026
http://dx.doi.org/10.1515/raon-2015-0013

Ejemplares similares